BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25840287)

  • 1. Comment on the article by Barra et al. entitled 'Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations'.
    Wilson DG; Zeljko HM; Leventopoulos G; Morgan JM
    Europace; 2015 Sep; 17(9):1455-6. PubMed ID: 25840287
    [No Abstract]   [Full Text] [Related]  

  • 2. Authors' reply.
    Barra S; ProvidĂȘncia R; Paiva L; Heck P; Agarwal S
    Europace; 2015 Sep; 17(9):1456. PubMed ID: 25840283
    [No Abstract]   [Full Text] [Related]  

  • 3. Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations.
    Barra S; ProvidĂȘncia R; Paiva L; Heck P; Agarwal S
    Europace; 2015 Feb; 17(2):174-86. PubMed ID: 25480942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indications for pacemakers, implantable cardioverter-defibrillator and cardiac resynchronization devices.
    Samii SM
    Med Clin North Am; 2015 Jul; 99(4):795-804. PubMed ID: 26042883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When an implantable defibrillator fails. Here are the options when the leads on your device stop working.
    Harv Heart Lett; 2012 Aug; 22(12):3. PubMed ID: 23025020
    [No Abstract]   [Full Text] [Related]  

  • 6. Eligibility of cardiac resynchronization therapy patients for subcutaneous implantable cardioverter defibrillators.
    Moubarak G; Maison-Blanche P; Thomas O
    J Electrocardiol; 2018; 51(3):531-533. PubMed ID: 29273233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newer Indications for ICD and CRT.
    Merriam JA; Rajendra AB; Gold MR
    Cardiol Clin; 2014 May; 32(2):181-90. PubMed ID: 24793795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICD for Patients With Severe Renal Dysfunction.
    Amiya E
    Int Heart J; 2017 May; 58(3):303-304. PubMed ID: 28539574
    [No Abstract]   [Full Text] [Related]  

  • 9. Saving lives and reducing inappropriate device therapy: the MADIT family of implantable cardioverter-defibrillator and cardiac resynchronization therapy trials.
    Moss AJ
    Cardiol J; 2013; 20(3):217-9. PubMed ID: 23788293
    [No Abstract]   [Full Text] [Related]  

  • 10. Patient selection for implantable cardioverter defibrillators.
    Tanaka S
    Ann Thorac Cardiovasc Surg; 1998 Jun; 4(3):107-9. PubMed ID: 9714591
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical management of arrhythmias in elderly patients: results of the European Heart Rhythm Association survey.
    Chen J; Hocini M; Larsen TB; Proclemer A; Sciaraffia E; Blomström-Lundqvist C;
    Europace; 2015 Feb; 17(2):314-7. PubMed ID: 25634939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter defibrillators: therapy against Canada's leading killer.
    Davis DR; Tang AS
    CMAJ; 2004 Oct; 171(9):1037-8. PubMed ID: 15505261
    [No Abstract]   [Full Text] [Related]  

  • 13. [Implantable device treatment for the life threatening arrhythmias in ischemic heart disease].
    Ito M
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():494-502. PubMed ID: 22724253
    [No Abstract]   [Full Text] [Related]  

  • 14. Roles and indications for use of implantable defibrillator and resynchronization therapy in the prevention of sudden cardiac death in heart failure.
    Biton Y; Baman JR; Polonsky B
    Heart Fail Rev; 2016 Jul; 21(4):433-46. PubMed ID: 26910804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The "clinical cost" of implantable cardioverter-defibrillators in the primary prevention of sudden cardiac death is underestimated].
    Disertori M
    G Ital Cardiol (Rome); 2011 May; 12(5):374-8; discussion 378. PubMed ID: 21593957
    [No Abstract]   [Full Text] [Related]  

  • 16. Subcutaneous implantable cardioverter defibrillator.
    Rowley CP; Gold MR
    Circ Arrhythm Electrophysiol; 2012 Jun; 5(3):587-93. PubMed ID: 22715237
    [No Abstract]   [Full Text] [Related]  

  • 17. The subcutaneous implantable cardioverter defibrillator: state-of-the-art review.
    McLeod CJ; Boersma L; Okamura H; Friedman PA
    Eur Heart J; 2017 Jan; 38(4):247-257. PubMed ID: 28182222
    [No Abstract]   [Full Text] [Related]  

  • 18. [The "clinical cost" of implantable cardioverter-defibrillators in the primary prevention of sudden cardiac death should not restrict their use].
    Francia P; Cappato R
    G Ital Cardiol (Rome); 2011 May; 12(5):379-82; discussion 382. PubMed ID: 21593958
    [No Abstract]   [Full Text] [Related]  

  • 19. Implantable cardioverter defibrillators in children.
    Chun TU; Collins KK; Dubin AM
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):561-71. PubMed ID: 15225115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of implantable cardioverter-defibrillators: from trials to the real world.
    De Sousa J
    Rev Port Cardiol; 2005 Apr; 24(4):501-4. PubMed ID: 15977774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.